|
RASGEF1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.21299999999991E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.55810000000067E-05 |
| Normal-vs-Stage2 |
9.603900E-03 |
| Normal-vs-Stage3 |
3.815400E-01 |
| Normal-vs-Stage4 |
5.956300E-03 |
| Stage1-vs-Stage2 |
1.546640E-01 |
| Stage1-vs-Stage3 |
1.029600E-01 |
| Stage1-vs-Stage4 |
2.1100999836321E-09 |
| Stage2-vs-Stage3 |
2.956400E-02 |
| Stage2-vs-Stage4 |
9.790600E-04 |
| Stage3-vs-Stage4 |
4.519000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.83780000007472E-07 |
| Normal-vs-AfricanAmerican |
3.228400E-02 |
| Normal-vs-Asian |
9.408000E-01 |
| Caucasian-vs-AfricanAmerican |
1.576210E-01 |
| Caucasian-vs-Asian |
2.299400E-01 |
| AfricanAmerican-vs-Asian |
4.162200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.1372000000317E-06 |
| Normal-vs-Female |
2.055100E-03 |
| Male-vs-Female |
8.151600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.340610E-01 |
| Normal-vs-Extreme_Weight |
2.445200E-04 |
| Normal-vs-Obese |
6.764500E-03 |
| Normal-vs-Extreme_Obese |
3.215200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.965600E-01 |
| Normal_Weight-vs-Obese |
3.549000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.765800E-01 |
| Extreme_Weight-vs-Obese |
8.631000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.890400E-01 |
| Obese-vs-Extreme_Obese |
5.728000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.552800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.242070E-03 |
| Normal-vs-Age(61-80Yrs) |
2.68810000003672E-06 |
| Normal-vs-Age(81-100Yrs) |
5.693700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.659400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.158300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.039220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.236250E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.597400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.314400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.34300000015553E-07 |
| Normal-VS-Type2 PRCC |
1.062360E-02 |
| Normal-VS-KIRP CIMP |
6.029500E-02 |
| Normal-VS-Unclassified PRCC |
2.659600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.368400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.45219999999158E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
3.379800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.836600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.369600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.624000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.897620E-02 |
| Normal-vs-N1 |
4.089000E-01 |
| Normal-vs-N2 |
4.72309999999254E-07 |
| N0-vs-N1 |
9.999000E-03 |
| N0-vs-N2 |
5.50570000035222E-07 |
| N1-vs-N2 |
4.358800E-03 |
|
|
